Q32 Bio Inc.
QTTB
$3.65
$0.247.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.39M | -9.49M | -11.03M | -14.19M | -17.60M |
| Total Depreciation and Amortization | 91.00K | 91.00K | 119.00K | 120.00K | 123.00K |
| Total Amortization of Deferred Charges | 46.00K | 49.00K | 48.00K | 49.00K | 50.00K |
| Total Other Non-Cash Items | 1.33M | 2.01M | 607.00K | 1.62M | 1.18M |
| Change in Net Operating Assets | 1.69M | -3.31M | -2.23M | 974.00K | -3.28M |
| Cash from Operations | -4.23M | -10.65M | -12.48M | -11.43M | -19.52M |
| Capital Expenditure | -- | -- | -- | -2.00K | -58.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 10.00M |
| Cash from Investing | -- | -- | -- | -2.00K | 9.94M |
| Total Debt Issued | -- | -- | -- | -53.16M | 0.00 |
| Total Debt Repaid | -1.56M | -- | -- | 8.71M | 0.00 |
| Issuance of Common Stock | -- | -- | -- | 317.00K | 997.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 44.44M | -- |
| Cash from Financing | -1.56M | -- | -- | 317.00K | 997.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.79M | -10.65M | -12.48M | -11.11M | -8.58M |